NEXUS AG / Key word(s): Acquisition 09.02.2015 21:20 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- NEXUS AG completed a transaction to acquire 100% of the outstanding shares of quCare Solutions B.V. (NL), Utrecht, a leading HIS Company in the Netherlands. The total turnover of quCare was approximately EUR 15 million in 2013/2014. NEXUS has paid a purchase Price between EUR 15 and EUR 20 million and has identified significant synergies in the context of integrating the new company into the NEXUS Group. Both companies expect an increase in profitability, which should result in an increase in earnings per share (EPS) of 1 cent. quCare and NEXUS are planning to expand their joint activities in the Dutch market and to improve the market position of quCare further. With the addition of modules and products from NEXUS, quCare will be offering its customers the whole range of clinical and diagnostic information systems from a single source. Through this acquisition, NEXUS has completed another step in becoming a leading European E-Health company. NEXUS is actively combing eHealth know-how from different European countries in order to provide better products and services to the hospitals. 09.02.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: NEXUS AG Auf der Steig 6 78052 Villingen-Schwenningen Germany Phone: +49 (0)7721 8482-0 Fax: +49 (0)7721 8482-311 E-mail: [email protected] Internet: www.nexus-ag.de ISIN: DE0005220909 WKN: 522090 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------